WASHINGTON (AP) — The Biden administration is putting pharmaceutical companies on notice.
Washington is warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions.
Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost.
The administration did not immediately release details about how the process will work and how it will deem a drug costly enough to act.
If the plan is enacted, drugmakers are almost certain to sue.
